Introduction
Ulcerative colitis is an idiopathic inflammatory bowel disease characterized by intestinal inflammation, and the number of patients is increasing in developed countries 1 .
It has been reported that patients with active ulcerative colitis status have high activated macrophage, monocyte, and neutrophil counts in peripheral blood or inflamed gut 2, 3 .
The activated macrophages and monocytes generate proinflammatory cytokines, including tumor necrosis factor-α TNF-α 4, 5 , which induce inflammation in the intestines 6 .
Reactive oxygen species generated by the activated macrophages and neutrophils also contribute to intestinal oxidative injury in ulcerative colitis patients 7 . Thus, it has been believed that both inflammation and oxidative stress are involved in the development and progress of ulcerative cine 12 , beverages, cuisines, and cosmetics 13, 14 . It has been reported that yuzu contains many bioactive compounds that show anti-inflammatory and/or antioxidant activities, including ascorbic acid, β-carotene, flavonoids, and limonoids 15 . The extract of yuzu inhibits platelet aggregation, prevents myocardial infarction-induced ventricular dysfunction and structural remodeling of myocardium, and exerts an antidiabetic effect 11, 16, 17 . Although yuzu has many health benefits, there is no report of its beneficial effects on ulcerative colitis. In this study, we examined the effect of yuzu on ulcerative colitis induced by dextran sulfate sodium DSS in mouse. We found that yuzu peel significantly attenuated DSS-induced colitis symptoms due to the coordination between its anti-inflammatory and antioxidant effects.
Experimental

Extraction of yuzu peel and preparation of samples
Yuzu peel paste YP-01, which consists of yuzu peel after squeezing out the juice, was obtained from Shikoku Research Institute Inc. Kagawa, Japan . The yuzu peel paste was stored at 80 . For the extraction of the aqueous fraction, 10 g of frozen yuzu peel paste and 10 mL of cold serum-free RPMI 1640 medium Sigma-Aldrich, MO supplemented with 2 mM L-glutamine or cold phosphate-buffered saline PBS were transferred to a 50 mL conical centrifuge tube. The mixture was vortexed vigorously on the highest setting for 30 seconds to produce a suspension of yuzu peel paste. The suspension was further mixed in a rotator RT-5; TAITEC Corporation., Saitama, Japan at 2.5 r/min for 15 min at 5 , and then centrifuged at 1100 x g for 5 min at 5 . The resulting supernatant was used as 50 yuzu peel extract.
Quantitative analysis of avonoids and ascorbic acid
The 50 yuzu peel extract extracted with RPMI 1640 medium hereinafter, RPMI 1640 extract of yuzu peel was diluted 5-fold with DMSO/MeOH 1:1 v/v and then measured in a UFLC system Prominence UFLC; Shimadzu Corporation, Kyoto, Japan equipped with a Shim-pack XR-ODS column Shimadzu Corporation maintained at 30 at the flow rate of 0.6 mL/min. The absorbance at 280 nm was monitored. Formic acid 0.1 v/v ; A and 99.9 acetonitrile containing 0.1 formic acid B were used as the gradient elution system. The mobile phase was 95 A, which was decreased to 50 over a period of 18.7 min. It was further decreased to 5 A in 0.5 min and maintained at that concentration for another 1.5 min. Hesperidin Wako Pure Industries, Ltd., Osaka, Japan and naringin SigmaAldrich were dissolved in DMSO/MeOH 1:1 v/v and diluted to prepare standard solutions 8 μM to 324 μM for the creation of a calibration curve for each chemical. Each flavonoid was quantified on the basis of the calibration curve of hesperidin or naringin.
Ascorbic acid content in the yuzu peel extract extracted with PBS hereinafter, PBS extract of yuzu peel was determined with an Ascorbic Acid Colorimetric/Fluorometric Assay Kit BioVision, CA in accordance with the manufacturer s instructions.
Animals
Male BALB/c mice were purchased from Clea Japan Inc. Tokyo, Japan . The animals were fed a standard laboratory diet CE-2; Clea Japan Inc. and water ad libitum. The animal room was maintained at 23 2 and 50 10 humidity under a 12 h light 8:00-20:00 and dark 20:00-8:00 cycle. The animals were acclimated to the laboratory environment for at least one week before the experiment. All the experimental procedures were approved by the Institutional Animal Care and Use Committee of the National Institute of Advanced Industrial Science and Technology.
Mouse DSS-colitis model
Mice were randomly divided into four experimental groups: two groups 5 animals each were fed a diet containing 50 g/kg w/w yuzu peel paste daily for 14 d. The remaining two groups were fed a standard diet. One group fed yuzu peel paste was given drinking water containing 4 w/v DSS for 5 d to induce colitis while yuzu peel paste feeding was continued. One group fed the standard diet was also given drinking water containing 4 w/v DSS for 5 d. To determine the severity of clinical colitis, body weight, stool consistency, and visible fecal blood were evaluated daily. Stool consistency and visible fecal blood were scored as described by Melgar et al. 18 with slight modifications, as shown in Table 1 .
2.5 LPS-induced in ammation in vivo and measurement of plasma cytokines Male BALB/c mice 6 weeks old, 18 to 22 g without anesthesia were intraperitoneally administered 13 μg of lipopolysaccharide LPS with or without PBS extract of yuzu peel at various concentrations 200 μL/cavity . A mixture of LPS and yuzu peel extract for intraperitoneal administration was prepared by mixing in PBS. A 26-gauge, 1/2-inch injection needle Terumo Co., Tokyo, Japan and a 1 mL syringe Terumo Co., Tokyo, Japan were used for each 
Cells and cell culture
The murine macrophage-like cell line RAW 264.7 DS Pharma Biomedical Co., Osaka, Japan and RAW 264.7 cells expressing secreted embryonic alkaline phosphatase SEAP Raw-Blue cells, InvivoGen, CA were cultured in RPMI 1640 medium Sigma-Aldrich supplemented with 10 fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin, and were maintained at 37 in a humidified atmosphere of 5 CO 2 .
2.7 Measurement of TNF-α produced by RAW 264. 7 RAW 264.7 cells 1 10 5 cells/well were plated into 96-well plates for 4 h. The cells were treated with RPMI 1640 extract of yuzu peel at the concentration of 0 to 1 with or without LPS 250 ng/mL , and incubation was carried out for 24 h.
SEAP reporter assay
Raw-Blue cells 1 10 5 cells/well were plated into 96-well plates and treated with RPMI 1640 extract of yuzu peel at the concentration of 0 to 1 with LPS 50 ng/mL . Then, the cells were incubated for 24 h. SEAP activity in the supernatants was measured using Quanti-Blue InvivoGen .
2.9 Indirect immunofluorescence assays and confocal microscopy RAW 264.7 cells 2.5 10 4 cells/well were cultured in an 8-well cell culture chamber slide Thermo Fisher Scientific . The cells were treated with 1 RPMI 1640 extract of yuzu peel for 24 h at 37 , and then treated with LPS 50 ng/mL for 30 min at 37 . Subcellular localization of nuclear factor-κB NF-κB p65 was examined by indirect immunofluorescence assay as reporter previously 19 using a rabbit polyclonal antibody against p65 1:500, Cell Signaling Technology Inc., MA and an Alexa Fluor 546-conjugated goat anti-rabbit antibody 1:500, Thermo Fisher Scientific .
Nuclear counterstaining was performed with TO-PRO-3 1:10000, Thermo Fisher Scientific . The cells were imaged under a confocal laser scanning microscope LSM 700, Carl Zeiss, Oberkochen, Germany . Fluorescence intensity in the cytoplasm was determined from the p65 fluorescence intensity in the TO-PRO-3-negative region divided by the p65 fluorescence intensity in the entire region including the TO-PRO-3-positive region.
Measurement of lipid peroxidation
The antioxidant activity of PBS extract of yuzu peel was determined by measuring oxygen uptake as described previously 20 . Briefly, micelles were prepared by vigorously vortexing methyl linoleate 0.2 v/v in PBS containing 0.05 M cholic acid. Free-radical-mediated oxidation of methyl linoleate generates conjugated diene hydroperoxides together with the consumption of oxygen via a straightforward mechanism. The oxidation of methyl linoleate and its inhibition by antioxidants were monitored by oxygen uptake measurement using an oxygen monitor equipped with a Clark-type oxygen electrode YSI model 5300, OH at 37 . Hydrophilic 2,2 -azobis 2-amidinopropane dihydrochloride was used as an azo initiator.
Statistical analysis
Data are expressed as means standard error SE . Statistical analyses were performed using Prism version 5.0c GraphPad Software, CA . The statistical significance of any difference in each parameter among the groups was evaluated by one-way analysis of variance ANOVA and Dunnett s test as the post hoc test. p Values 0.05 were considered statistically significant.
Results and discussion
Characterization of bioactive components in yuzu peel
First, we analyzed the bioactive components in yuzu peel used in this study. RPMI 1640 extract of yuzu peel was subjected to HPLC and HPLC-MS/MS. The results showed that narirutin 774 12 μM , hesperetin 7-2,6-dirhamnosylglucoside 356 5 μM , naringin 513 10 μM , hesperidin 1118 15 μM , neohesperidin 635 9 μM , and rhamnetin 3-o-rutinoside concentration not determined were the major compounds Table 2 , Fig. S1 . The bioactive components and their concentration in PBS extract of yuzu peel were almost the same as those in the RPMI 1640 extract of yuzu peel data not shown . We also identified ascorbic acid 602 68 μM in the PBS extract of yuzu peel. These results suggest the possibility of yuzu peel having an attenuating effect on ulcerative colitis because the bioactive components identified in yuzu peel exhibit both anti- inflammatory and antioxidant effects.
3.2 Attenuating effect of yuzu peel in mouse DSS-induced colitis model Next, we examined whether yuzu peel attenuates DSSinduced colitis in a mouse model. Mice were fed powder diet containing 50 g/kg yuzu peel paste for 14 d and then given drinking water containing 4 w/v DSS for 5 d to induce colitis while yuzu peel paste feeding was continued. Mice given DSS showed typical colitis symptoms, including weight loss Fig. 1A , white circles , diarrhea Fig. 1B , white circles , rectal bleeding Fig. 1C , white circles , and colon shortening caused by edematous inflammation of the colon 21 Fig . 1D , yuzu -and DSS . Diarrhea Fig. 1B , black circles and visible fecal blood Fig. 1C , black circles were significantly attenuated in DSS-treated mice fed yuzu peel. In addition, colon shortening was also significantly suppressed Fig. 1D, yuzu and DSS . We noted that TNF-α and IL-12 levels in the culture supernatants from a section of colon in DSS-treated mice fed yuzu peel tended Fig. 1 Attenuating effect of yuzu peel on DSS-induced colitis. Mice were fed powder diet containing 50 g/kg yuzu peel paste for 14 d and then given drinking water containing 4 w/v DSS for 5 d to induce colitis while yuzu peel paste feeding was continued. The attenuating effect of yuzu peel was evaluated in terms of A body weight, B diarrhea score, C visible fecal blood score, and D colon length. Data are expressed as means SE of five animals in each group. * p 0.05, ** p 0.01 for comparison of DSS-treated mice fed the standard diet DSS with DSS-treated mice fed diet containing yuzu peel DSS + yuzu . A Body weight change was calculated using body weight on day 0 as the initial body weight. D Relative colon length was compared with that of non-treated mice fed the standard diet yuzu-and DSS-.
to be lower than those in the DSS-treated mice fed the standard diet, although these differences were not statistically significant Fig. S2 . Furthermore, we examined the plasma levels of totally assessed hydroxyeicosatetraenoic acids tHETEs , which are the lipid peroxidation products of the free and ester forms of arachidonic acids. The plasma levels of tHETEs 5-, 12-, and 15-HETEs tended to be suppressed in mice fed yuzu peel compared to those fed the control diet with and without DSS, although the differences were not statistically significant 22 Fig. S3 . These results suggested that yuzu peel partially suppressed inflammation of the colon and oxidative stress. On the other hand, the phenotypes of non-treated mice fed diet containing yuzu peel were not significantly different from those of non-treated mice fed the standard diet Fig. 1 . Together, these results demonstrate that yuzu peel had an attenuating effect on DSS-induced colitis.
Anti-in ammatory effect of yuzu peel
To elucidate the mechanism underlying the attenuating effect of yuzu peel on DSS-induced colitis, we investigated the anti-inflammatory effect of yuzu peel in vivo and in vitro. In the in vivo experiment, 13 μg of LPS and PBS extract of yuzu peel of different concentrations were simultaneously administered intraperitoneally into the mice. Plasma was collected at 1, 3, and 6 h for measurements of TNF-α, IL-12, and IFN-γ, respectively, based on our previous finding of the peak times of the respective proinflammatory cytokines in plasma of LPS-treated mice 23 . As shown in Fig. 2A , TNF-α level in plasma of mice injected with 0.5 yuzu peel extract was significantly reduced compared with that of mice treated with LPS alone. The levels of IL-12 and IFN-γ also tended to decrease, but the decrease was not statistically significant Fig. 2A . Suppression of TNF-α production was also observed in RAW264.7 cells Fig. 2B without exhibiting cytotoxicity Fig. S4 . These results demonstrated that yuzu peel has anti-inflammatory effect, as reported previously 12, 16 .
It has been reported that the activation of the NF-κB pathway, a representative proinflammatory signaling pathway 24 , following production of proinflammatory cytokines, including TNF-α, is deeply involved in the pathogenesis of DSS-induced colitis 25 . We therefore examined whether yuzu peel suppresses the activation of the NF-κB pathway by using SEAP-expressing RAW 264.7 cells RawBlue cells in which SEAP reporter is expressed under the control of NF-κB response elements 26 . RAW 264.7 cells were simultaneously treated with 50 ng/mL of LPS and different concentrations of RPMI 1640 extract of yuzu peel, and SEAP protein secreted into the culture medium was measured after incubation for 24 h. As shown in Fig. 3A , yuzu peel extract significantly suppressed LPS-induced SEAP production, demonstrating that the extract potentially suppressed the activation of the NF-κB pathway.
To further confirm whether yuzu peel extract suppresses endogenous NF-κB pathway activation, we performed immunohistochemical analysis of p65 protein, a major subunit of NF-κB. NF-κB exists in an inactive form in the cytoplasm owing to its interaction with IκBα, an inhibitor of NF-κB. After activation of IκB kinase by stimulation, including LPS and TNF-α, IκBα is phosphorylated, ubiquitinated, and degraded by proteasomes. The dissociated NF-κB becomes free to translocate to the nucleus where it activates specific target genes through selective binding to the NF-κB response element. Through such mechanisms, NF-κB regulates the expression of a wide variety of genes, including TNF-α. Thus, the activation of the NF-κB pathway is characterized by the translocation of p65 from the cytoplasm to the nucleus.
To examine the subcellular localization of p65, RAW 264.7 cells were pretreated with RPMI 1640 extract of yuzu peel for 24 h, and then treated with LPS for 30 min. As show in Fig. 3B , whereas p65 was localized in the cytosol in unstimulated cells upper panel , it was translocated to the nucleus by LPS stimulation middle panel . As expected, p65 partially remained in the cytoplasm by the pretreatment with yuzu peel extract Fig. 3B , bottom panel . Quantitative analysis demonstrated that the LPS-induced translocation of p65 from the cytoplasm to the nucleus was suppressed by yuzu peel extract Fig. 3C , indicating that yuzu peel extract suppresses the activation of the endogenous NF-κB pathway by inhibiting upstream of IκBα phosphorylation.
Hesperidin, which is present in yuzu peel extract in a large amount, has been reported to exert an inhibitory effect on NF-κB-mediated inflammatory responses 27 . Naringin also has been reported to inhibit LPS-induced endotoxin shock in mice by suppressing NF-κB pathway activation 28 . In addition, neohesperidin has been found to inhibit receptor activator of NF-κB ligand RANKL -induced activation 29 . Thus, although we cannot identify all the yuzu peel components involved in NF-κB suppression, it may be reasonable to assume that flavonoids, including hesperidin and naringin, play an important role in the suppression of NF-κB pathway activation.
Antioxidant effect of yuzu peel against lipid
Finally, we investigated the antioxidant effect of yuzu peel based on its radical scavenging activity. Antioxidant effect was examined by using the method for monitoring methyl linoleate oxidation, as reported previously 20 . The same concentrations of ascorbic acid and hesperidin in PBS extract of yuzu peel were tested as controls, because we have identified the large amounts of hesperidin and ascorbic acid in yuzu peel extract. As shown in Fig. 4 , ascorbic acid showed radical scavenging activity at the early stage of oxidation, whereas hesperidin exhibited radical scavenging activity at the later stage. The reason for this is unknown; nevertheless, we speculate that the oxidation products of hesperidin generated by radicals may be also effective against the next-coming radicals formed at the later stage. It is interesting that yuzu peel extract, whose hesperidin and ascorbic acid concentrations are the same as those of hesperidin and ascorbic acid positive controls, inhibited the oxidation much more efficiently than those controls. This may be attributed to the fact that antioxidative compounds other than ascorbic acid and hesperidin are present in the extract and flavonoids other than hesperidin contributed synergistically to the total antioxidant effect 30 . It is therefore concluded that yuzu peel extract possesses moderate antioxidative effect against radicals and its effect is stronger than that of ascorbic acid and hesperidin at the same concentration.
Conclusion
We demonstrated that yuzu peel extract has an attenuating effect on DSS-induced symptoms, including weight loss, colon shortening, diarrhea, and visible fecal blood. We confirmed that yuzu peel extract suppressed LPS-stimulated TNF-α production Fig. 2 and showed radical scavenging activity Fig. 4 , demonstrating that yuzu peel possesses both anti-inflammatory and antioxidant effects. Thus, it may be reasonable to assume that yuzu peel attenuated DSS-induced colitis symptoms due to the coordination between anti-inflammatory effect and antioxidant effect against lipids in vivo.
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